Background/Aims: Methamphetamine abuse may produce cognitive impairment. Baicalein, a bioactive flavonoid, has antioxidative, anti-inflammatory and neuroprotective effects. This study examined the effects of baicalein pretreatment on memory performance in the passive avoidance test after either one dose or an acute binge of methamphetamine in Institute of Cancer Research (ICR) mice. Methods: Methamphetamine was administered by intraperitoneal (i.p.) injection of either one dose (3 mg/kg) or an acute binge (3 mg/kg, 4 i.p. injections at 2-hour intervals). The effects of baicalein pretreatment (1 mg/kg, i.p.) on methamphetamine-induced changes of locomotor activity and memory performance were compared with those of eticlopride, a selective dopamine D2 receptor antagonist. The effects of baicalein on acute binge methamphetamine-induced oxidative stress (malondialdehyde- and nitrotyrosine-modified protein production) in the mouse hippocampus were also examined. Results: One-dose methamphetamine treatment (i.p., 30 min before or immediately after the training trial) induced hyperlocomotion and amnesia in mice, which were blocked by eticlopride but not by baicalein pretreatment. The memory performance in mice was impaired 5 days after acute binge methamphetamine, which was significantly attenuated by baicalein but not by eticlopride pretreatment. Baicalein pretreatment also attenuated acute binge methamphetamine-induced oxidative stress in the mouse hippocampus. Conclusions: Baicalein exhibits antioxidative and neuroprotective effects in attenuating acute binge methamphetamine-induced memory deficits and oxidative hippocampal damage.

Keywords:
Baicalein, Methamphetamine, Eticlopride, Amnesia, Passive avoidance test, Neuroprotective effect, Hippocampus
1.
Davidson C, Gow AJ, Lee TH, Ellinwood EH: Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Rev 2001;36:1-22.
2.
Nordahl TE, Salo R, Leamon M: Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. J Neuropsychiatry Clin Neurosci 2003;15:317-325.
3.
Meredith CW, Jaffe C, Ang-Lee K, Saxon AJ: Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry 2005;13:141-154.
4.
Segal DS, Kuczenski R: Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization. J Pharmacol Exp Ther 1997;282:561-573.
5.
Roozendaal B, Carmi O, McGaugh JL: Adrenocortical suppression blocks the memory-enhancing effects of amphetamine and epinephrine. Proc Natl Acad Sci USA 1996;93:1429-1433.
6.
Bisagno V, Ferguson D, Luine VN: Short toxic methamphetamine schedule impairs object recognition task in male rats. Brain Res 2002;940:95-101.
7.
Silva RH, Kameda SR, Carvalho RC, Rigo GS, Costa KL, Taricano ID, Frussa-Filho R: Effects of amphetamine on the plus-maze discriminative avoidance task in mice. Psychopharmacology (Berl) 2002;160:9-18.
8.
Yamamoto BK, Zhu W: The effects of methamphetamine on the production of free radicals and oxidative stress. J Pharmacol Exp Ther 1998;287:107-114.
9.
Liu YY, Yen PH, Wang GJ, Huang SW, Chi CW, Ho LK, Pan HT: Baicalein reverses the methamphetamine-induced striatal dopaminergic neurotoxicity in mice. J Food Drug Anal 2006;14:317-322.
10.
Park MJ, Lee SK, Lim MA, Chung HS, Cho SI, Jang CG, Lee SM: Effect of α-tocopherol and deferoxamine on methamphetamine-induced neurotoxicity. Brain Res 2006;1109:176-182.
11.
Wu PH, Shen YC, Wang YH, Chi CW, Yen JC: Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum. Toxicology 2006;226:238-245.
12.
Tokunaga I, Ishigami A, Kubo S, Gotohda T, Kitamura O: The peroxidative DNA damage and apoptosis in methamphetamine-treated rat brain. J Med Invest 2008;55:241-245.
13.
Hamada H, Hiramatru M, Edamatsu R, Mori A: Free radical scavenging action of baicalein. Arch Biochem Biophys 1993;306:261-266.
14.
Lin CC, Shieh DE: The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. Am J Chin Med 1996;1:31-36.
15.
Wang SY, Wang HH, Chi CW, Chen CF, Liao JF: Effects of baicalein on β-amyloid peptide-(25-35)-induced amnesia in mice. Eur J Pharmacol 2004;506:55-61.
16.
Liu C, Wu J, Gu J, Xiong Z, Wang F, Wang J, Wang W, Chen J: Baicalein improves cognitive deficits induced by chronic cerebral hypoperfusion in rats. Pharmacol Biochem Behav 2007;86:423-430.
17.
Wang HH, Chien JW, Chou YC, Liao JF, Chen CF: Anti-amnesic effect of dimemorfan in mice. Br J Pharmacol 2003;138:941-949.
18.
Venault P, Chapouthier G, de Carvalho LP, Simiand J, Morre M, Dodd RH, Rossier J: Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasks. Nature 1986;321:864-866.
19.
Matsuno K, Senda T, Matsunaga K, Mita S: Ameliorating effects of σ receptor ligands on the impairment of passive avoidance tasks in mice: involvement in the central acetylcholinergic system. Eur J Pharmacol 1994;261:43-51.
20.
He J, Yang Y, Yu Y, Li X, Li XM: The effects of chronic administration of quetiapine on the methamphetamine-induced recognition memory impairment and dopaminergic terminal deficit in rats. Behav Brain Res 2006;172:39-45.
21.
Wiig KA, Whitlock JR, Epstein MH, Carpenter RL, Bear MF: The levo enantiomer of amphetamine increases memory consolidation and gene expression in the hippocampus without producing locomotor stimulation. Neurobiol Learn Mem 2009;92:106-113.
22.
Nguyen EC, McCracken KA, Liu Y, Pouw B, Matsumoto RR: Involvement of sigma (σ) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies. Neuropharmacology 2009;49:638-645.
23.
Imam SZ, Crow JP, Newport GD, Islam F, Slikker W Jr, Ali SF: Methamphetamine generates peroxynitrite and produces dopaminergic neurotoxicity in mice: protective effects of peroxynitrite decomposition catalyst. Brain Res 1999;837:15-21.
24.
Gluck MR, Moy LY, Jayatilleke E, Hogan KA, Manzino L, Sonsalla PK: Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. J Neurochem 2001;79:152-160.
25.
Oh SB, Park HR, Jang YJ, Choi SY, Son TG, Lee J: Baicalein attenuates impaired hippocampal neurogenesis and the neurocognitive deficits induced by γ-ray radiation. Br J Pharmacol 2013;168:421-431.
26.
Krasnova IN, Cadet JL: Methamphetamine toxicity and messengers of death. Brain Res Rev 2009;60:379-407.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.